Southwestern Idaho Bridges to Baccalaureate (SWID B2B) program is a 3-year support and research program for students at CWI that intend to transfer to Boise State and pursue biomedical research. The program aims to increase the number of underrepresented students in Idaho that are interested in the biomedical sciences.
The program successfully prepares students for careers in the biomedical sciences by providing enhanced advising and peer mentoring, a paid research experience, and continued engagement at Boise State through research and specialized B2B courses. B2B is funded by a grant from the National Institutes of Health.
B2B Year 1
CWI students are assigned a peer mentor and enroll in Ethics (SCIE 102). Second semester students are assigned a faculty mentor and enroll in Cell Biology and Genetics to prepare for the summer research experience!
Summer Experience: B2B students participate in the funded Bridges Summer Research Experience for 10 weeks with a distinguished faculty mentor.
B2B Year 2
B2B students have successfully transferred to Boise State and continue to participate in a 15 week paid research experience. Students also take a year-long Bridges Professional Development course (BIOL 375).
B2B Year 3+
B2B students serve as peer mentors for the new B2B cohort and receive continued academic and financial support through undergraduate research and specialized B2B course work.
Criteria for Admission to the B2B Program
In addition to completing the application and meeting the following criteria for the program, the B2B leadership team will conduct interviews in person with B2B finalists.
Students must belong to at least one of the following categories:
- Rural residency, as determined by your zip code at the time you applied to CWI
- Ethnic minority (Hispanic, African American, American Indian, or Pacific Islander);
- Self-identified as first generation
- Veteran Status, or
- Receive accommodations for any of the following, vision or hearing impairment, mobility impairment, learning disability, or a disability or impairment no listed.
Questions about B2B?
Dr. Steve Lysne